ArticleDrug design, development and therapy2025

Plasma Concentrations of Prophylactic Posaconazole and Risk Factors for Subtherapeutic Exposure in Taiwanese Patients with Hematologic Malignancies.

Hsing-Yu Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.